Clinical Trial Update: Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicates completion of Phase 2 and Phase 3 studies evaluating Bacillus clausii for irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Bacillus clausii (Bacillus clausii)

Snippet

Sponsor: Hospital Britanico | Conditions: Irritable Bowel Syndrome | Phase 2, Phase 3 | Status: COMPLETED